“With this acquisition, LANXESS is forming a champion in the field of additives and strengthens its already profitable portfolio” Matthias Zachert, CEO, LANXESS.

For LANXESS, the acquisition of Chemtura will be accretive to earnings per share (EPS) in the first fiscal year, with annual synergies of approximately EUR 100 million expected by 2020. LANXESS is paying an EV/EBITDA multiple of approximately 7x including synergies for this transaction, meeting its target of 7-9x for acquisitions including synergies.

Through the acquisition LANXESS shareholders benefit from

  • a more resilient and profitable chemical company
  • a competitive positioning in medium-sized markets
  • increasing presence in North America

Chemtura on the other hand becomes part of a much larger, stronger global enterprise with the resources to fully support a more diverse suite of specialty chemicals products and services.

Latest Press Releases

Chemtura shareholders approve acquisition by LANXESS

Cologne – Specialty chemicals company LANXESS (FRA: LXS) has taken a significant step forward in the planned acquisition of U.S. chemical company Chemtura (NYSE: CHMT). Chemtura’s shareholders approved the merger at a special meeting in Philadelphia, United States.

LANXESS successfully issues first hybrid bond

2016-11-29 | Cologne – Specialty chemicals company LANXESS today successfully issued a hybrid bond with a volume of EUR 500 million on the European capital market. The proceeds of the transaction are to be used for the financing of the planned acquisition of US-based chemical company Chemtura.

LANXESS successfully places two EUR 500 million corporate bonds

2016-09-29 | Cologne – LANXESS announced today that it has successfully placed two Euro benchmark bonds on the European capital market for the financing of the planned acquisition of the US-based specialty chemicals group Chemtura.